- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 1.85 Å
- Oligo State
- hetero-1-1-1-mer
- Ligands
- 16 x IOD: IODIDE ION(Non-functional Binders)
- 27 x EDO: 1,2-ETHANEDIOL(Non-functional Binders)
EDO.13: 7 residues within 4Å:- Chain A: R.95, C.98, E.99, F.100, I.287, F.288, P.289
Ligand excluded by PLIPEDO.14: 7 residues within 4Å:- Chain A: K.81, Q.86, Q.355, A.356, S.357, Y.362
- Ligands: CNC.36
Ligand excluded by PLIPEDO.15: 9 residues within 4Å:- Chain A: Q.63, R.102, G.103, K.105, G.106
- Chain B: D.26, L.27, D.28
- Ligands: IOD.42
Ligand excluded by PLIPEDO.16: 7 residues within 4Å:- Chain A: K.121, R.122, G.125, H.126, S.156, K.160
- Ligands: EDO.33
Ligand excluded by PLIPEDO.17: 5 residues within 4Å:- Chain A: G.223, N.224, L.388
- Ligands: EDO.24, EDO.34
Ligand excluded by PLIPEDO.18: 10 residues within 4Å:- Chain A: W.23, N.33, I.36, Q.266, N.267, A.268, L.269, L.358, S.359, G.360
Ligand excluded by PLIPEDO.19: 12 residues within 4Å:- Chain A: R.41, L.42, R.95, A.96, N.97, K.281, D.285, L.286, P.289, D.290, C.291
- Ligands: IOD.12
Ligand excluded by PLIPEDO.20: 5 residues within 4Å:- Chain A: L.319, S.320, E.403, R.405, L.406
Ligand excluded by PLIPEDO.21: 6 residues within 4Å:- Chain A: S.69, A.70, F.71, D.77, C.78, Q.79
Ligand excluded by PLIPEDO.22: 6 residues within 4Å:- Chain A: A.123, G.130, H.131, P.132, H.133, E.373
Ligand excluded by PLIPEDO.23: 3 residues within 4Å:- Chain A: W.115, D.119, R.122
Ligand excluded by PLIPEDO.24: 7 residues within 4Å:- Chain A: S.174, D.176, N.224, S.227
- Ligands: EDO.17, EDO.30, CNC.36
Ligand excluded by PLIPEDO.25: 5 residues within 4Å:- Chain A: T.186, K.189, R.190, I.205, S.238
Ligand excluded by PLIPEDO.26: 7 residues within 4Å:- Chain A: S.83, M.84, G.85, F.116, T.134, Q.138
- Ligands: EDO.32
Ligand excluded by PLIPEDO.27: 2 residues within 4Å:- Chain A: L.319, P.324
Ligand excluded by PLIPEDO.28: 8 residues within 4Å:- Chain A: H.173, S.174, V.175, A.178, E.211, I.212, A.215
- Ligands: IOD.2
Ligand excluded by PLIPEDO.29: 3 residues within 4Å:- Chain A: Y.352, E.353, T.354
Ligand excluded by PLIPEDO.30: 7 residues within 4Å:- Chain A: H.172, S.174, D.176, T.177, W.409
- Ligands: EDO.24, CNC.36
Ligand excluded by PLIPEDO.31: 9 residues within 4Å:- Chain A: Q.317, L.380, R.381, D.382, P.383, N.384, T.401, E.403, R.405
Ligand excluded by PLIPEDO.32: 7 residues within 4Å:- Chain A: F.116, D.119, E.120, A.123, H.133, T.134
- Ligands: EDO.26
Ligand excluded by PLIPEDO.33: 12 residues within 4Å:- Chain A: G.125, H.126, D.127, H.128, S.156, D.159, K.160, R.197
- Chain C: D.115, Y.116
- Ligands: IOD.3, EDO.16
Ligand excluded by PLIPEDO.34: 8 residues within 4Å:- Chain A: T.217, E.219, H.221, G.223, N.224, V.225, L.388
- Ligands: EDO.17
Ligand excluded by PLIPEDO.35: 10 residues within 4Å:- Chain A: Q.64, L.67, G.68, S.69, A.70, F.71, S.72, E.73
- Chain B: P.18
- Ligands: IOD.40
Ligand excluded by PLIPEDO.43: 4 residues within 4Å:- Chain B: G.103, P.105, S.110, E.113
Ligand excluded by PLIPEDO.44: 4 residues within 4Å:- Chain C: Q.39, C.45, Y.95, W.117
Ligand excluded by PLIPEDO.45: 1 residues within 4Å:- Chain C: R.122
Ligand excluded by PLIPEDO.46: 8 residues within 4Å:- Chain A: Y.163, F.168
- Chain C: N.97, Y.114, Y.116, W.117, G.118
- Ligands: IOD.3
Ligand excluded by PLIP- 1 x CNC: CYANOCOBALAMIN(Non-covalent)
CNC.36: 42 residues within 4Å:- Chain A: S.83, G.85, Q.86, L.89, T.134, S.135, Y.137, Q.138, L.141, S.174, D.176, T.177, N.224, Y.226, S.227, L.230, N.267, L.269, M.270, Q.273, S.357, L.358, S.359, G.360, P.361, Y.362, L.363, F.376, W.377, Q.378, L.379, P.386, L.387, L.388, Q.389, G.390, I.391, W.409
- Ligands: IOD.11, EDO.14, EDO.24, EDO.30
40 PLIP interactions:39 interactions with chain A, 1 Ligand-Ligand interactions- Hydrophobic interactions: A:L.89, A:Y.137, A:Y.137, A:Y.137, A:L.141, A:D.176, A:Y.226, A:Y.362, A:F.376, A:F.376, A:L.379
- Hydrogen bonds: A:Q.86, A:T.134, A:S.135, A:Y.137, A:D.176, A:N.224, A:N.224, A:Y.226, A:S.227, A:Q.273, A:Q.273, A:L.358, A:S.359, A:L.363, A:L.363, A:L.379, A:L.379
- Water bridges: A:Y.137, A:Y.137, A:Q.138, A:Q.138, A:Y.226, A:N.267, A:N.267, A:R.374, A:R.374, A:W.377, A:G.390
- Metal complexes: CNC.36
- 2 x CA: CALCIUM ION(Non-covalent)
CA.37: 7 residues within 4Å:- Chain A: K.114
- Chain B: W.99, D.102, H.104, D.106, D.112, E.113
6 PLIP interactions:6 interactions with chain B- Metal complexes: B:W.99, B:D.102, B:H.104, B:D.106, B:D.112, B:E.113
CA.38: 7 residues within 4Å:- Chain A: K.105
- Chain B: W.21, D.24, D.26, D.28, D.34, E.35
6 PLIP interactions:6 interactions with chain B- Metal complexes: B:W.21, B:D.24, B:D.26, B:D.28, B:D.34, B:E.35
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Bloch, J.S. et al., Generation of nanobodies targeting the human, transcobalamin-mediated vitamin B 12 uptake route. Faseb J. (2022)
- Release Date
- 2022-03-16
- Peptides
- Transcobalamin-2: A
CD320 antigen: B
Anti-transcobalamin-2 nanobody TC-Nb34: C - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
CC
B
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 1.85 Å
- Oligo State
- hetero-1-1-1-mer
- Ligands
- 16 x IOD: IODIDE ION(Non-functional Binders)
- 27 x EDO: 1,2-ETHANEDIOL(Non-functional Binders)
- 1 x CNC: CYANOCOBALAMIN(Non-covalent)
- 2 x CA: CALCIUM ION(Non-covalent)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Bloch, J.S. et al., Generation of nanobodies targeting the human, transcobalamin-mediated vitamin B 12 uptake route. Faseb J. (2022)
- Release Date
- 2022-03-16
- Peptides
- Transcobalamin-2: A
CD320 antigen: B
Anti-transcobalamin-2 nanobody TC-Nb34: C - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
CC
B